−12.4
Chemomab Therapeutics Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−20.4
FY23:
−23.6
FY24:
−15.4
FY25:
−11.1
Change from FY21 to FY25
millions USD
FY21:
−45.2
FY22:
19.5
FY23:
15.9
FY24:
2.30
FY25:
5.39
Change from FY21 to FY25
millions USD
FY21:
61.1
FY22:
−0.81
FY23:
3.50
FY24:
9.87
FY25:
7.16
millions USD
FY21:
3.51
FY22:
−1.65
FY23:
−4.23
FY24:
−3.22
FY25:
1.42
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.6
FY22:
−20.4
FY23:
−23.6
FY24:
−15.4
FY25:
−11.1
All amounts in millions USD